The details of the relative TAGLN2 mRNA expression levels and the ratio of CD38+ cells among CD19+ B-cells or CD19+CD27+ B-cells in SLE patients and controls are given in S1 Table. The gene discussed is CD38; the disease is systemic lupus erythematosus.